Annual Multicancer Early Detection Test Not Associated with a Lower Incidence Rate of Stage III or IV Cancer After Three Screening Rounds and 12 Months of Follow-Up By Ogkologos - October 1, 2026 43 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the the NHS-Galleri study Source RELATED ARTICLESMORE FROM AUTHOR ESMO launches new principles for humanising scientific reporting to strengthen the communication of cancer research Clinical Activity of Talazoparib Plus Enzalutamide Demonstrated in Patients with High-Volume mHNPC, but Without Clear Benefit Over Enzalutamide in Biomarker-Unselected Population FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma MOST POPULAR VA Study Finds No Disparities in Prostate Cancer Deaths with Equal... February 18, 2020 Adding PD1 Inhibitor to Neoadjuvant Chemotherapy Significantly Increases the pCR Rate... February 12, 2025 News on the Passing of the Lymphedema Treatment Act! January 23, 2023 Man Who Lost Wife to Breast Cancer Wants to Donate Her... June 5, 2021 Load more HOT NEWS How Therapy Helped Me Cope During Cancer: A Survivor’s Perspective Adagrasib Shows Promising Activity as Monotherapy, Even Greater in Combination with... EMA Recommends Extension of Indications for Sugemalimab The ecDNA story – catching the mastermind behind cancer evolution
